Abstract 36: The Boston Criteria V2.0 for Cerebral Amyloid Angiopathy: Updated Criteria and Multicenter MRI-Neuropathology Validation
Autor: | Gregoire Boulouis, Edip M Gurol, Jean-Claude Baron, Matthew P. Frosch, Andreas Charidimou, Anand Viswanathan, Rustam Al-Shahi Salman, Marco Pasi, Eric E. Smith, Mark A. van Buchem, Steven M. Greenberg, David J. Werring |
---|---|
Rok vydání: | 2021 |
Předmět: |
Advanced and Specialized Nursing
Intracerebral hemorrhage Pathology medicine.medical_specialty medicine.diagnostic_test business.industry Magnetic resonance imaging Neuropathology medicine.disease medicine Neurology (clinical) Cerebral amyloid angiopathy Cardiology and Cardiovascular Medicine business Amyloid angiopathy |
Zdroj: | Stroke. 52 |
ISSN: | 1524-4628 0039-2499 |
Popis: | Introduction: The Boston criteria are used worldwide for in vivo diagnosis of cerebral amyloid angiopathy (CAA). Given substantial advances in CAA research, we aimed to update the Boston criteria and externally validate their diagnostic accuracy across the spectrum of CAA-related presentations and across international sites. Methods: As part of an International CAA Association multicenter study, we identified patients age 50 or older with potential CAA-related clinical presentations (spontaneous intracerebral hemorrhage, cognitive impairment, or transient focal neurological episodes), available brain MRI, and histopathologic assessment for the diagnosis of CAA. We derived Boston criteria v2.0 by selecting MRI features to optimize diagnostic specificity and sensitivity in a pre-specified derivation sample (Boston cases 1994 to 2012, n=159), then externally validated in pre-specified temporal (Boston cases 2012-2018, n=59) and geographical (non-Boston cases 2004-2018; n=123) validation samples and compared their diagnostic accuracy to the currently used modified Boston criteria. Results: Based on exploratory analyses in the derivation sample, we derived provisional criteria for probable CAA requiring presence of at least 2 strictly lobar hemorrhagic lesions (intracerebral hemorrhage, cerebral microbleed, or cortical superficial siderosis focus) or at least 1 strictly lobar hemorrhagic lesion and 1 white matter characteristic (severe degree of visible perivascular spaces in centrum semiovale or white matter hyperintensities multispot pattern). Sensitivity/specificity of the criteria were 74.8/84.6% in the derivation sample, 92.5/89.5% in the temporal validation sample, 80.2/81.5% in the geographic validation sample, and 74.5/95.0% in cases across all samples with autopsy as the diagnostic gold standard. The v2.0 criteria for probable CAA had superior accuracy to the currently modified Boston criteria (p Conclusion: The Boston criteria v.2.0 incorporate emerging MRI markers of CAA to enhance sensitivity without compromising their high specificity. Validation of the criteria across independent patient settings firmly supports their adoption into clinical practice and research. |
Databáze: | OpenAIRE |
Externí odkaz: |